<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Many studies have shown a relationship between long-term endurance sport practice and <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain><z:mp ids='MP_0001845'>Inflammation</z:mp>, anatomic remodelling, alterations in the autonomic system and neurohormonal activation are <z:hpo ids='HP_0000001'>all</z:hpo> possible explanations for the increased prevalence of this <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> in athletes </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0005110'>Atrial fibrillation</z:hpo> may determine disabling symptoms like <z:hpo ids='HP_0001962'>palpitations</z:hpo> and impaired physical performance, compromising eligibility for competitive activities, but exclusion from sport is not necessary for <z:hpo ids='HP_0000001'>all</z:hpo> athletes </plain></SENT>
<SENT sid="3" pm="."><plain>Limited data are available on drug therapy and recently ablation resulted to be a particularly attractive option for young athletes with <z:hpo ids='HP_0004757'>paroxysmal atrial fibrillation</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>The purpose of this review is to discuss mechanisms, clinical features, management of <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> in competitive athletes, including criteria for eligibility and disqualification in sport practice </plain></SENT>
</text></document>